Skip to main content

Final results for the financial year ended 31 March 2026

       ICG plc 21 May 2026 Final ResultsFor the financial year ended 31 March 2026 Highlights Strategic and AUMDelivering significant growth from flagship and scaling strategies, maintaining disciplined approach to investment performance and a focus on cash realisations (DPI) AUM of $126bn; fee-earning AUM of $87bn, up 11%1 y-o-y, five-year annualised growth of 14%1 Fundraising of $17bn, exceeding our expectationsFinancialFinancial presentation evolved to be in line with global alternative asset management peers, in particular a focus on FRE Management fees of £685m, up 13%2 y-o-y; FRE of £350m / 120p per share up 23%3 y-o-y, five-year annualised growth of 30%3 Performance fee income of £127m4 (FY25: £86m) Balance sheet investment portfolio5 of £2,568m Group operating cashflow of £861m (FY25: £533m) Net debt of £113m (FY25:...

Continue reading

Multitude AG publishes Q1 results: Continued execution and portfolio growth

Zug, 21 May 2026 – Multitude AG, a listed European FinTech company offering digital lending and online banking services to consumers, SMEs, and institutional clients (“Multitude”, the “Company” or the “Group”), today publishes its Q1 2026 results for the period ending 31 March 2026. Multitude Group Results Group revenue stood at EUR 61.6 million compared to EUR 66.8 million in Q1 2025, reflecting changes to product offering and portfolio composition. On a quarterly run-rate basis, revenue remained broadly stable (Q4 2025: EUR 61.0 million; Q3 2025: EUR 62.5 million). Group fee and commission income increased significantly by EUR 2.5 million year-on-year to EUR 4.9 million, driven mainly by Consumer Banking. Net loans and investments expanded by 23.5% to EUR 971.6 million (Q1 2025: EUR 786,541 million). Total assets increased by 14.8% to...

Continue reading

TCM Group A/S: Interim report Q1 2026 (January 1 – March 31)

COMPANY ANNOUNCEMENT No. 267/2026         Tvis, 21 May 2026 Interim report Q1 2026 (January 1 – March 31) (All figures in brackets refer to the corresponding period in 2025) A fairly strong start to the year in a volatile market CEO Torben Paulin:“Sales in the first quarter developed as expected, with increasing sales both within B2B and B2C. Revenue in Q1 was DKK 362.4 million, compared to DKK 308.1 million in Q1 2025. Organically, sales in the quarter increased by 8.2% year on year. Sales to Norway contributed positively to the growth in the quarter, growing slightly more than the sales in Denmark. Overall order intake in the quarter was above last year, driven by the B2C segment. Order intake within the B2B segment was below last year primarily driven by fewer large project orders. Additionally, we observed a continued recovery...

Continue reading

Ackermans & van Haaren (Trading Update Q1 2026): Strong start to the year of core participations. Confirmation of guidance.

Dear shareholder, Dear Madam, Dear Sir,Please find attached our press release with the trading update for the first quarter of 2026, highlighting:Strong start to the year of the core participations Confirmation of guidance: net profit of 2026 is expected to be roughly in line with the record result of 2025 Positive net financial position of 410.8 million eurosBest regards Ackermans & van HaarenAttachmentAvH-Trading-Update-First-Quarter-2026

Continue reading

First quarter 2026 update: starting the year on track, with product innovation progress

Louvain-la-Neuve, Belgium, 21 May 2026 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group OverviewSolid commercial momentum, particularly in IBA Technologies driven by RadioPharma Solutions, followed by an active pipeline in Proton Therapy. Backlog stable at €1.6 billion, including €0.73 billion and €0.83 billion in equipment and services backlog respectively. FY2026 adjusted EBIT guidance reaffirmed of at least €32 million, reflecting confidence in the Group’s full-year outlook. Net debt position stable at €57 million1 as of March 31, 2026, with €15 million of revolving credit facilities used. Working capital cycle remains driven by large proton therapy project deliveries, with share buyback progress and anticipated supplier payments...

Continue reading

BTS Group AB (publ) Interim report January – March 2026

BTS back to profitable growth January 1 – March 31, 2026Net sales amounted to MSEK 602 (647). Growth adjusted for currency effects was 5%, whereof 2% was organic. EBITA increased 5 % to MSEK 62 (59). EBITA margin was 10.3 (9.1) %. Profit after tax increased 4% to MSEK 26 (25). Earnings per share increased 7% to SEK 1.42 (1.33).“BTS is back to profitable growth, with our biggest unit, North America, returning to growth and 50 percent profit improvement. In North America, AI companies are increasingly turning to BTS as their partner of choice and our clients are recognizing that the key to applied AI advancement is a people and leadership issue – right in our sweet spot.” Jessica Skon, CEO of BTS Group AB Outlook 2026 We estimate that the result (EBITA) for 2026 will be better than 2025.  FINANCIAL SUMMARY Jan-Mar Jan-Mar Apr-Mar Jan-DecMSEK 2026 2025 2025/2026 2025Net...

Continue reading

iPower Reports Fiscal Third Quarter 2026 Results Highlighted by Lower Operating Cost Structure, Narrowed Non-GAAP Loss and Advancing AI Infrastructure Strategy

Operating expenses declined 66% sequentially GAAP net loss primarily reflected non-cash goodwill impairment; non-GAAP net loss narrowed to $0.3 million Company strengthens platform through asset-light operations, contracted sublease income and recently launched AI infrastructure strategy RANCHO CUCAMONGA, Calif., May 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a technology- and data-driven company operating at the intersection of supply chain, infrastructure and digital assets, today reported financial results for its fiscal third quarter ended March 31, 2026. Fiscal third quarter results reflected continued progress in iPower’s strategic operating reset following the divestiture of Global Product Marketing Inc. and the Company’s transition toward a leaner, more asset-light operating model. For...

Continue reading

NVIDIA Announces Financial Results for First Quarter Fiscal 2027

NVIDIA corporate headquartersNVIDIA corporate headquarters in Silicon ValleyRecord revenue of $81.6 billion, up 85% from a year ago Record Data Center revenue of $75.2 billion, up 92% from a year ago NVIDIA announces $80.0 billion additional share repurchase authorization and increases its quarterly cash dividend from $0.01 per share to $0.25 per shareSANTA CLARA, Calif., May 20, 2026 (GLOBE NEWSWIRE) — NVIDIA (NASDAQ: NVDA) today reported record revenue for the first quarter ended April 26, 2026, of $81.6 billion, up 20% from the previous quarter and up 85% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 74.9% and 75.0%, respectively. For the quarter, GAAP and non-GAAP earnings per diluted share were $2.39 and $1.87, respectively. “The buildout of AI factories — the largest infrastructure expansion...

Continue reading

OMNIQ Reports First Quarter 2026 Financial Results

OMNIQ Reports 7.7 Million in First Quarter Revenues SALT LAKE CITY, May 20, 2026 (GLOBE NEWSWIRE) — OMNIQ Corp (OTCMTS: OMQS or “OMNIQ” or “the Company”) today announced its financial results for the first quarter 2026. The Company reported $7.7 million in quarterly revenue as well as a gross profit increase of 3.3 percent year over year. The Company continues to implement its product focus and cost-reduction strategy designed to increase revenue & footprint, strengthen profitability, and support long-term operational efficiency. Financial Highlights For the three months ended March 31, 2026, compared to the same period in 2025:Revenue was $7.68 million, compared to $7.98 million in the prior-year period. Gross profit increased to $2.255 million, compared to $2.184 million last year. Loss from operations was ($1.2 million),...

Continue reading

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today reported financial results and operating highlights for the first quarter ended March 31, 2026. Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer, stated “Our significant revenue increase year over year and quarter over quarter confirms what we emphatically stated when we reported our 2025 year end results last month: that the fourth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.